Diseases, Conditions, Syndromes

Three major scientific controversies about coronavirus

Although political leaders have closed borders in response to COVID-19, scientists are collaborating like never before. But the coronavirus (SARS-COV-2) is novel—and we don't yet have all the facts about it. As a result, ...

Diseases, Conditions, Syndromes

Drug prevents multiple sclerosis relapses in phase 3 trial

A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS)—the most common ...

Oncology & Cancer

Adverse effects from cancer drug trials explained

A team of researchers investigating how a certain type of drugs can kill cells has discovered that these drugs can do more harm than good when used in combination with other cancer treatments.

Diseases, Conditions, Syndromes

Virus antibodies fade fast but not necessarily protection

New research suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness, but that doesn't mean protection also is gone or that it won't be possible ...

Immunology

Coronavirus: B cells and T cells explained

To get the upper hand on the coronavirus, we first need to understand how our immune system reacts to it. Understanding this will lead to better treatments, effective vaccines and knowing how near we are to herd immunity—and ...

page 38 from 40